Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Arold eyes Micron, adds SXC Health

Michael Arold of the Technical Swing model has memory chipmaker Micron Tech (MU) in his sights as a possible buy candidate following this week’s earnings miss.

“If it doesn’t sell off too much more following the report, that’s a strong sign that everyone else has sold already and there’s upside to come,” Arold says.

Micron Technology, Inc. (NASDAQ:MU)

The chipmaker posted higher-than-expected sales on weak margins, especially on NAND flash memory. Shares sold off as much as 5% on the report.

Yet the company also is coming out with new products, which he notes should help to improve margins in the future. The long-term support Arold is watching is around $5.

New purchases for the model this week include Steel Dynamics (STLD) at around $11. Arold now holds a position worth less than 5% of his total portfolio. He thinks that the stock is in the process of bottoming, and that months of selling now are exhausted.

“A radical reversal could always happen, but it’s moving to the upside and I want to hold the position as long as possible,” Arold said. “I see potential for it to go to $13 or $14.

Another new buy is SXC Health Solutions (SXCI) at $95, initially taking a position worth about 10% of his portfolio. The stock trades at 32 times earnings, but consistently reports strong double-digit sales growth with little debt on the balance sheet.

What Arold likes most, however, is price momentum in the stock as it approaches $100, out of several months of sideways price movement.

Also of note, Arold took a profit on his former top holding, Ross Stores (ROST), dropping about 30% of his total position.

“But I could still see this stock developing into a long-term position based on its momentum,” he said. “As long as it’s still outperforming the S&P 500, I’m on board.”

Start Covesting with as little as $30,000. We mirror the actions of our managers in your account. Talk to us. We can help you find a great investment model that matches your goals.

Covestor Ltd. is a registered investment advisor. Covestor licenses investment strategies from its Model Managers to establish investment models. The commentary here is provided as general and impersonal information and should not be construed as recommendations or advice. Information from Model Managers and third-party sources deemed to be reliable but not guaranteed. Past performance is no guarantee of future results. Transaction histories for Covestor models available upon request. Additional important disclosures available at For information about Covestor and its services, go to or contact Covestor Client Services at (866) 825-3005, x703.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!